Inari Medical, Inc. Common Stock
NARI US45332Y1091
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 8% | -35% | 7% | -22% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Hoffman William |
60.13 USD |
141,075 Sold |
8,482,840 USD |
06/01/2025 | 06/01/2025 |
| Hoffman William |
61.27 USD |
58,925 Sold |
3,610,335 USD |
06/01/2025 | 06/01/2025 |
| Hykes Andrew CEO |
55.20 USD |
2,400 Sold |
132,480 USD |
20/12/2024 | 20/12/2024 |
| Hykes Andrew CEO |
55.65 USD |
600 Sold |
33,390 USD |
20/12/2024 | 20/12/2024 |
| Hoffman William |
55.23 USD |
20,917 Sold |
1,155,246 USD |
16/12/2024 | 16/12/2024 |
| Hoffman William |
56.82 USD |
2,347 Sold |
133,357 USD |
16/12/2024 | 16/12/2024 |
| Hoffman William |
54.42 USD |
2,100 Sold |
114,282 USD |
16/12/2024 | 16/12/2024 |
| Hoffman William |
54.33 USD |
3,176 Sold |
172,552 USD |
16/12/2024 | 16/12/2024 |
| Hoffman William |
56.45 USD |
13,560 Sold |
765,462 USD |
16/12/2024 | 16/12/2024 |
| Hoffman William |
55.27 USD |
10,301 Sold |
569,336 USD |
16/12/2024 | 16/12/2024 |